Quarterly report · Q3
7459.TEDINET S100Q61E
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.57T | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥3.29T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.51T | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥37.0bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥49.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥62.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥56.7bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥52.2bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥29.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥28.8bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥37.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥36.7bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥1.81T | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥1.71T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.78T | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.13T | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥1.06T | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥678.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥649.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥649.5bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥252.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥243.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥142.16 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.65 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.32 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.09 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥136.4 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131.41 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥128.87 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 30.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.9% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥7.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | ¥44m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥56.2bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥848.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥847.9bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥253m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.67T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.66T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.57T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥37.5bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | ¥391m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥54.8bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥54.8bn |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2m |
| jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥802.1bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥801.8bn |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥260m |
| jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥20.2bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.65T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.65T |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.6bn |
| jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥14.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥2.51T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥2.51T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥36.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 384
| Item | Context | Value | Unit |
|---|---|---|---|
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)㈱メディパルホールディングス | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都中央区八重洲二丁目７番15号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |